Victoria Redmond, PA
Physician Assistant · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Alta Bates Summit Medical Center - Alta Bates Camp · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Victoria Redmond’s office to ask if they take your plan before you enroll.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$71,688
Medicare paid this office $71,688 for 271 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of knee joint, both sides of knee | 114 | $18,040 | $156 |
| Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 16 | $14,314 | None |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 20 | $10,353 | None |
| Replacement of thigh bone and hip joint with prosthesis | 58 | $9,137 | $155 |
| Short return visit (20+ min) | 99 | $8,634 | $68 |
See all 9 services
| Replacement of knee joint, both sides of knee | 114 | $18,040 | $156 |
| Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 16 | $14,314 | None |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 20 | $10,353 | None |
| Replacement of thigh bone and hip joint with prosthesis | 58 | $9,137 | $155 |
| Short return visit (20+ min) | 99 | $8,634 | $68 |
| Aspiration and/or injection of fluid from large joint | 65 | $5,399 | $61 |
| Short return visit | 14 | $586 | $42 |
| Injection, methylprednisolone acetate, 1 mg | 21 | $227 | None |
| Injection, methylprednisolone acetate, 40 mg | 13 | $126 | None |
Procedures Medicare counted
| Hip replacement | 70 | More than 93% of doctors who do this |
| Knee replacement | 109 | More than 94% of doctors who do this |
Who their Medicare patients are
271 Original Medicare patients in 2024. Average age 74 · Women 68% · Also on Medicaid 16% · Health risk score 1.04. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Chronic kidney disease 34% · Diabetes 21% · Coronary heart disease 21% · Depression 20% · Cancer 19% · Atrial fibrillation 17% · COPD 15% · Heart failure 12% · Dementia 4% · Stroke 4%.
The office billed $2,042,224, Medicare allowed $92,981 and paid $71,688; for 5,693 services of 23 kinds; $27,415 of it was for drugs given in the office and $44,273 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 271 | 5,693 | 74 | 1.04 | $2,042,224 | $71,688 |
| 2023 | 227 | 4,368 | 75 | 1.04 | $942,860 | $65,179 |
| 2022 | 147 | 2,356 | 75 | 0.86 | $370,639 | $36,693 |
| 2021 | 69 | 310 | 75 | 0.93 | $259,726 | $11,242 |
| 2020 | 105 | 440 | 73 | 1.15 | $136,110 | $11,376 |
| 2019 | 266 | 1,505 | 73 | 1.02 | $76,016 | $47,263 |
| 2018 | 256 | 1,292 | 72 | 1.15 | $70,396 | $42,281 |
| 2017 | 88 | 281 | 73 | 1.25 | $13,488 | $7,525 |
| 2016 | 48 | 53 | 73 | 1.02 | $5,935 | $1,867 |
| 2014 | 24 | 89 | 73 | 1.03 | $77,767 | $5,911 |
| 2013 | 16 | 69 | 74 | 0.89 | $55,083 | $5,572 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 30 | $13,210 | None |
| Hyaluronan or derivative, monovisc, for intra-articular injection, per dose | 11 | $12,155 | None |
| Short return visit (20+ min) | 129 | $10,834 | $65 |
| Replacement of knee joint, both sides of knee | 47 | $8,344 | $178 |
| Aspiration and/or injection of fluid from large joint | 98 | $7,795 | $57 |
| Replacement of thigh bone and hip joint with prosthesis | 24 | $4,014 | $161 |
| New patient visit (30+ min) | 31 | $2,322 | $75 |
| Short return visit | 12 | $640 | $43 |
| Injection, methylprednisolone acetate, 40 mg | 17 | $346 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 47 | $340 | None |
| Telehealth originating site facility fee | 11 | $269 | $22 |
2022: 6 services
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 14 | $10,715 | None |
| Short return visit (20+ min) | 94 | $8,129 | $68 |
| Aspiration and/or injection of fluid from large joint | 75 | $5,171 | $54 |
| Replacement of thigh bone and hip joint with prosthesis | 17 | $2,858 | $159 |
| New patient visit (30+ min) | 30 | $2,263 | $75 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 54 | $343 | None |
2021: 4 services
| Replacement of knee joint, both sides of knee | 24 | $3,691 | $154 |
| Short return visit (20+ min) | 20 | $1,474 | $70 |
| Aspiration and/or injection of fluid from large joint | 22 | $1,370 | $60 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $96 | None |
2020: 5 services
| Short return visit (20+ min) | 57 | $2,083 | $33 |
| Aspiration and/or injection of fluid from large joint | 42 | $1,861 | $32 |
| Short return visit | 24 | $463 | $17 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 45 | $164 | None |
| Injection, methylprednisolone acetate, 40 mg | 44 | $163 | None |
2019: 9 services
| Short return visit (20+ min) | 212 | $13,497 | $47 |
| Aspiration and/or injection of fluid from large joint | 119 | $10,327 | $42 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 13 | $7,982 | None |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 14 | $4,533 | None |
| Short return visit | 81 | $3,363 | $30 |
| New patient visit (30+ min) | 27 | $1,654 | $61 |
| Injection, methylprednisolone acetate, 40 mg | 127 | $946 | None |
| Aspiration and/or injection of fluid from small joint | 24 | $919 | $31 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 128 | $496 | None |
2018: 10 services
| Aspiration and/or injection of fluid from large joint | 122 | $11,122 | $39 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 24 | $8,899 | None |
| Short return visit (20+ min) | 148 | $8,645 | $47 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 11 | $3,542 | None |
| Short return visit | 61 | $2,407 | $29 |
| New patient visit (15+ min) | 51 | $2,097 | $41 |
| Injection, methylprednisolone acetate, 40 mg | 126 | $874 | None |
| Aspiration and/or injection of fluid from small joint | 19 | $827 | $30 |
| Aspiration and/or injection of fluid from medium joint | 14 | $507 | $34 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 126 | $250 | None |
2017: 5 services
| Short return visit (20+ min) | 39 | $1,913 | $49 |
| Aspiration and/or injection of fluid from large joint | 32 | $1,789 | $40 |
| Short return visit | 18 | $489 | $27 |
| Injection, methylprednisolone acetate, 40 mg | 27 | $120 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 32 | $77 | None |
2016: 2 services
| Short return visit (20+ min) | 24 | $901 | $36 |
| Short return visit | 14 | $228 | $16 |
2014: 1 service
| Return visit (30+ min) | 13 | $1,140 | $81 |
Medicaid work
$0 in 2020
Medicaid paid $0 for 51 billed services this clinician did in 2020, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 51 | $0 |
| 2020 | 51 | 1 | 18 | $0 |
| 2019 | 455 | 5 | 28 | $0 |
| 2018 | 240 | 3 | 23 | $1,841 |
See the largest Medicaid services in earlier years
2019
| Arthrocentesis and injection of knee joint | 37 | $0 |
| Short return visit | 69 | $0 |
| Short return visit (20+ min) | 265 | $0 |
| Injection, methylprednisolone acetate, 40 mg | 42 | $0 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 42 | $0 |
2018
| Short return visit (20+ min) | 203 | $1,841 |
| Injection, methylprednisolone acetate, 40 mg | 25 | $0 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $0 |
Drugs they prescribed that Part D paid
$40,069
Pharmacies billed $40,069 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 45% of their Part D prescriptions (611 of 1,368) in 2024. A higher opioid share than 9 in 10 peers; the typical physician assistant clinician is at 1%.
1,324 generic and 44 brand-name prescriptions · $40,069 in drug cost · 69 antibiotic prescriptions to 47 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 40 | $23,628 | $591 |
| Celecoxib | 178 | $6,506 | $37 |
| Oxycodone | 444 | $3,157 | $7 |
| Hydrocodone-Acetaminophen | 84 | $1,182 | $14 |
| Omeprazole | 176 | $966 | $5 |
See all 15 drugs
| Eliquis | 40 | $23,628 | $591 |
| Celecoxib | 178 | $6,506 | $37 |
| Oxycodone | 444 | $3,157 | $7 |
| Hydrocodone-Acetaminophen | 84 | $1,182 | $14 |
| Omeprazole | 176 | $966 | $5 |
| Cyclobenzaprine | 76 | $753 | $10 |
| Meloxicam | 68 | $293 | $4 |
| Ondansetron Odt | 25 | $249 | $10 |
| Mupirocin | 33 | $240 | $7 |
| Tramadol | 53 | $172 | $3 |
| Oxycodone-Acetaminophen | 12 | $136 | $11 |
| Amoxicillin | 51 | $91 | $2 |
| Acetaminophen-Codeine | 11 | $83 | $8 |
| Ondansetron | 12 | $70 | $6 |
| Gabapentin | 11 | $60 | $5 |
Year by year
| 2024 | 1,368 | 303 | 45% (611) | 3% | $40,069 |
| 2023 | 646 | 222 | 49% (319) | 4% | $25,480 |
| 2022 | 341 | 165 | 50% (170) | None | $5,863 |
| 2021 | 287 | 129 | 53% (152) | None | $3,836 |
| 2020 | 94 | 50 | 56% (53) | None | $2,059 |
| 2019 | 122 | 75 | 39% (48) | None | $7,275 |
| 2018 | 142 | 75 | 20% (28) | 31% | $15,682 |
| 2017 | 577 | 197 | 34% (195) | 17% | $34,096 |
| 2016 | 593 | 191 | 35% (210) | 18% | $35,626 |
| 2015 | 350 | 140 | 37% (128) | 26% | $23,408 |
| 2014 | 217 | 42 | 54% (117) | 18% | $17,880 |
| 2013 | 123 | 26 | 68% (84) | 14% | $7,159 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Eliquis | 20 | $11,931 | $597 |
| Celecoxib | 125 | $3,225 | $26 |
| Oxycodone | 169 | $1,180 | $7 |
| Diclofenac | 21 | $463 | $22 |
| Tramadol | 97 | $362 | $4 |
| Hydrocodone-Acetaminophen | 33 | $315 | $10 |
| Cyclobenzaprine | 19 | $177 | $9 |
| Mupirocin | 16 | $172 | $11 |
| Meloxicam | 19 | $57 | $3 |
| Amoxicillin | 24 | $56 | $2 |
2022: 9 drugs
| Celecoxib | 28 | $1,064 | $38 |
| Naloxone | 11 | $1,046 | $95 |
| Hydrocodone-Acetaminophen | 69 | $638 | $9 |
| Oxycodone | 50 | $578 | $12 |
| Gabapentin | 18 | $513 | $29 |
| Diclofenac | 14 | $219 | $16 |
| Oxycodone-Acetaminophen | 15 | $182 | $12 |
| Amoxicillin | 44 | $105 | $2 |
| Tramadol | 30 | $100 | $3 |
2021: 8 drugs
| Hydrocodone-Acetaminophen | 70 | $688 | $10 |
| Celecoxib | 15 | $520 | $35 |
| Diclofenac | 16 | $388 | $24 |
| Oxycodone-Acetaminophen | 27 | $276 | $10 |
| Gabapentin | 11 | $191 | $17 |
| Oxycodone | 25 | $151 | $6 |
| Amoxicillin | 31 | $81 | $3 |
| Tramadol | 23 | $61 | $3 |
2020: 2 drugs
| Hydrocodone-Acetaminophen | 26 | $189 | $7 |
| Tramadol | 16 | $40 | $3 |
2019: 5 drugs
| Diclofenac | 23 | $3,197 | $139 |
| Celecoxib | 14 | $351 | $25 |
| Oxycodone-Acetaminophen | 18 | $144 | $8 |
| Tramadol | 21 | $83 | $4 |
| Naproxen | 11 | $61 | $6 |
2018: 7 drugs
| Xarelto | 11 | $4,500 | $409 |
| Diclofenac | 26 | $4,332 | $167 |
| Voltaren | 13 | $3,122 | $240 |
| Celecoxib | 14 | $1,372 | $98 |
| Oxycodone-Acetaminophen | 13 | $147 | $11 |
| Gabapentin | 11 | $127 | $12 |
| Naproxen | 14 | $110 | $8 |
2017: 11 drugs
| Voltaren | 60 | $12,996 | $217 |
| Diclofenac | 58 | $7,337 | $127 |
| Celecoxib | 55 | $5,460 | $99 |
| Oxycodone | 78 | $1,164 | $15 |
| Gabapentin | 68 | $714 | $10 |
| Tramadol | 90 | $370 | $4 |
| Hydrocodone-Acetaminophen | 14 | $184 | $13 |
| Clindamycin | 16 | $55 | $3 |
| Amoxicillin | 26 | $50 | $2 |
| Tamsulosin | 21 | $42 | $2 |
| Atorvastatin | 21 | $39 | $2 |
2016: 13 drugs
| Voltaren | 72 | $15,626 | $217 |
| Celecoxib | 66 | $9,552 | $145 |
| Diclofenac | 28 | $2,894 | $103 |
| Oxycodone | 102 | $2,303 | $23 |
| Enoxaparin | 12 | $1,954 | $163 |
| Tramadol | 78 | $439 | $6 |
| Hydrocodone-Acetaminophen | 11 | $301 | $27 |
| Ibuprofen | 17 | $241 | $14 |
| Gabapentin | 26 | $236 | $9 |
| Tamsulosin | 42 | $91 | $2 |
| Amoxicillin | 30 | $75 | $3 |
| Atorvastatin | 33 | $70 | $2 |
| Warfarin | 12 | $31 | $3 |
2015: 9 drugs
| Voltaren | 57 | $9,961 | $175 |
| Celecoxib | 25 | $3,296 | $132 |
| Oxycodone | 41 | $1,176 | $29 |
| Hydrocodone-Acetaminophen | 23 | $806 | $35 |
| Tramadol | 53 | $303 | $6 |
| Tamsulosin | 25 | $141 | $6 |
| Warfarin | 23 | $42 | $2 |
| Amoxicillin | 12 | $39 | $3 |
| Atorvastatin | 21 | $38 | $2 |
2014: 4 drugs
| Butrans | 13 | $4,522 | $348 |
| Hydrocodone-Acetaminophen | 68 | $2,046 | $30 |
| Tizanidine | 19 | $839 | $44 |
| Oxycodone | 11 | $286 | $26 |
2013: 2 drugs
| Hydrocodone-Acetaminophen | 47 | $998 | $21 |
| Hydromorphone | 13 | $416 | $32 |
Money from drug and device companies
$182 in 2025
A payment is not proof that care is biased.
| Zimmer Biomet Holdings | None | $182 | 1 payment
|
See the published payment
| Zimmer Biomet Holdings | Meals · 2025-10-30 | None | $182 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1346507555
- Licence
- CA 22178
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X); Physician assistant, surgical (363AS0400X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2012-04-12
- NPI last updated
- 2025-12-23
- NPI record certified
- 2025-12-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2180 Main St, Wailuku, HI, 96793